| [ Summary ] |
The primary goal of osteoporosis treatment is to reduce the risk of fragility fractures in elderly people, and the time has come for us to act against these fractures using several established and newly developed anti-osteoporotic drugs. Not only do we have to prescribe those drugs appropriately, but it is also essential to provide long-term and consistent treatment for patients with osteoporosis. Therefore, we need to know what patients are to be treated, which drug is appropriate for each individual patient, and how to treat the patients consistently in the long-term. |